MAP Insights

NICE Models for the evaluation and purchase of antimicrobials – what next?

In response to the challenges associated with discovering, developing and bringing new antimicrobial drugs to market, the National Institute for Health and Care Excellence (NICE) and NHS England and NHS Improvement (NHSE&I) developed a project to create a world-first pull incentive. Yesterday,  the project leapt forward as NICE published the draft guidance for cefiderocol and ceftazidime with avibactam.

Arrow Vector-Quotes